
Pharma Pulse 6/5/24: Pediatric Weight Crucial to Perfecting the Dose, AI Employees Aren’t Free to Voice Concerns & more
The latest news for pharma industry insiders.
A retrospective study explores the connection between adherence and racial/ethnic disparities among patients with Alzheimer’s disease, along with similar dementias.
Evidence indicates that up to 25% of all prescriptions for children could be dosed inappropriately, making it the most common type of medication administration error.
Industry experts, in a roundtable discussion, explore the evolution of brand engagement in the age of AI, including the growing importance of message relevance—and, for pharma, going where the information is.
A group of current and former OpenAI and DeepMind employees want more whistleblower protections and fear retaliation.
Funding provided to school-based telehealth provider Hazel Health, who will partner with school systems across Iowa to enable access to mental health support for approximately 100,000 K-12 students
Great to see my friend Cheryl Mahon who works on Pharmaceutical Commerce Magazine, Pharmaceutical Executive and Applied Clinical Trials Magazine! Whew! At MJH Life Sciences®
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
